Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for NEVIF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
November 30, 2025 0.00
August 31, 2025 0.1816M
May 31, 2025 0.1785M
February 28, 2025 0.1676M
November 30, 2024 0.2972M
August 31, 2024 0.00
May 31, 2024 0.00
February 29, 2024 0.00
November 30, 2023 0.00
August 31, 2023 0.00
May 31, 2023 0.00
February 28, 2023 0.00
November 30, 2022 0.00
August 31, 2022 0.00
May 31, 2022 0.00
February 28, 2022 0.00
November 30, 2021 0.00
August 31, 2021 0.00
Date Value
May 31, 2021 0.00
February 28, 2021 0.00
November 30, 2020 0.00
August 31, 2020 0.00
May 31, 2020 0.00
February 29, 2020 0.00
November 30, 2019 0.00
August 31, 2019 0.00
May 31, 2019 0.00
February 28, 2019 0.00
November 30, 2018 0.00
August 31, 2018 0.00
May 31, 2018 0.00
February 28, 2018 0.00
November 30, 2017 0.00
August 31, 2017 0.00
May 31, 2017 0.00
February 28, 2017 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 22.46M
Integrated BioPharma, Inc. 2.207M
BioForce Nanosciences Holdings, Inc. 0.00
Skinvisible, Inc. 5.724M
Skinhealth Systems, Inc. 363.18M